Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples